Government Action Plan Aims to Make Better Use of Resources for Drug Industry

A government action plan supporting R+D and medical biotechnology in Hungary's drug industry aims to increase competitiveness.

A government action plan supporting R+D and medical biotechnology in Hungary's drug industry aims to increase competitivenessthrough the better use of funding available to the sector, state secretary in charge of competitiveness at the National Development and Economy Ministry Mr Zoltan Mester said at a press conference on July 9.
The action plan lays down short-term measures intended to repair the sector's deteriorating competitiveness and establish the conditions for growth in the long term.
As part of the plan, Hungary wants to introduce the "young innovative company" status, which allows companies to have a greater access to support.

News Monitoring